Skip to content

Clinical trials

Observational Cardiovascular Diseases trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Observational Country / region: Hong Kong Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20121
20141
20161
20171
20181
20202
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong4
The University of Hong Kong3
Boston Scientific Corporation2
Abbott Medical Devices1
AstraZeneca1
Medtronic1
Medtronic Cardiac Rhythm and Heart Failure1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases13
Diabetes Mellitus3
Heart Diseases2
Arrhythmias, Cardiac1
Atherosclerosis1
Atrial Fibrillation1
Cardiac Conduction System Disease1
Coronary Artery Disease1
Coronary Disease1
Diabetes Mellitus, Type 11

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.